Ultragenyx Pharmaceutical and Mereo BioPharma Group saw their shares plummet after ringing out 2025 by announcing the failures of their brittle bone disease candidate setrusumab (UX143) in a pair of ...
Morning Overview on MSN
Start/stop engines are dying, here’s what finally killed the feature
For more than a decade, automatic engine start/stop systems were sold as painless climate tech, a clever way to trim fuel use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback